BRSK2 | BR serine/threonine kinase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
MOB2 | MOB kinase activator 2 | | | | | | Expressed in all |
DUSP8 | Dual specificity phosphatase 8 | Enzymes
| | | | | Mixed |
KRTAP5-1 | Keratin associated protein 5-1 | | | | | | Not detected |
KRTAP5-2 | Keratin associated protein 5-2 | | | | | | Not detected |
KRTAP5-3 | Keratin associated protein 5-3 | | | | | | Not detected |
KRTAP5-4 | Keratin associated protein 5-4 | | | | | | Not detected |
KRTAP5-5 | Keratin associated protein 5-5 | | | | | | Not detected |
KRTAP5-6 | Keratin associated protein 5-6 | | | | | | Not detected |
IFITM10 | Interferon induced transmembrane protein 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-295K3.1 | | Predicted membrane proteins
| | | | | Mixed |
CTSD | Cathepsin D | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
SYT8 | Synaptotagmin VIII | Predicted membrane proteins
| | | | | Tissue enhanced |
TNNI2 | Troponin I type 2 (skeletal, fast) | Disease related genes
| | | | | Tissue enriched |
LSP1 | Lymphocyte-specific protein 1 | | | | | | Expressed in all |
C11orf89 | Chromosome 11 open reading frame 89 | | | | | | Tissue enhanced |
TNNT3 | Troponin T type 3 (skeletal, fast) | Disease related genes
| | | | | Tissue enriched |
MRPL23 | Mitochondrial ribosomal protein L23 | Mitochondrial proteins Ribosomal proteins
| | | | | Expressed in all |
IGF2 | Insulin-like growth factor 2 (somatomedin A) | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
INS-IGF2 | INS-IGF2 readthrough | Predicted secreted proteins
| | | | | Tissue enriched |
INS | Insulin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
TH | Tyrosine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enriched |
ASCL2 | Achaete-scute family bHLH transcription factor 2 | Transcription factors
| | | | | Mixed |
C11orf21 | Chromosome 11 open reading frame 21 | | | | | | Tissue enhanced |
TSPAN32 | Tetraspanin 32 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TSSC4 | Tumor suppressing subtransferable candidate 4 | | | | | | Expressed in all |
TRPM5 | Transient receptor potential cation channel, subfamily M, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CDKN1C | Cyclin-dependent kinase inhibitor 1C (p57, Kip2) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
SLC22A18AS | Solute carrier family 22 (organic cation transporter), member 18 antisense | | | | | | Tissue enhanced |
SLC22A18 | Solute carrier family 22, member 18 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
PHLDA2 | Pleckstrin homology-like domain, family A, member 2 | | | | | | Tissue enhanced |
NAP1L4 | Nucleosome assembly protein 1-like 4 | Plasma proteins
| | | | | Expressed in all |
AC131971.1 | HCG1782999; PRO0943; Uncharacterized protein | | | | | | Not detected |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
OSBPL5 | Oxysterol binding protein-like 5 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MRGPRG | MAS-related GPR, member G | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
MRGPRE | MAS-related GPR, member E | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
ZNF195 | Zinc finger protein 195 | Transcription factors
| | | | | Expressed in all |
ART5 | ADP-ribosyltransferase 5 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ART1 | ADP-ribosyltransferase 1 | CD markers Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
CHRNA10 | Cholinergic receptor, nicotinic, alpha 10 (neuronal) | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
NUP98 | Nucleoporin 98kDa | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
PGAP2 | Post-GPI attachment to proteins 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
RHOG | Ras homolog family member G | Plasma proteins
| | | | | Expressed in all |
STIM1 | Stromal interaction molecule 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
RRM1 | Ribonucleotide reductase M1 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
OR52B4 | Olfactory receptor, family 52, subfamily B, member 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
TRIM21 | Tripartite motif containing 21 | Plasma proteins
| | | | | Expressed in all |